154 related articles for article (PubMed ID: 10669358)
1. Interferon-gamma expression in jejunal biopsies in experimental human cryptosporidiosis correlates with prior sensitization and control of oocyst excretion.
White AC; Robinson P; Okhuysen PC; Lewis DE; Shahab I; Lahoti S; DuPont HL; Chappell CL
J Infect Dis; 2000 Feb; 181(2):701-9. PubMed ID: 10669358
[TBL] [Abstract][Full Text] [Related]
2. Expression of IL-15 and IL-4 in IFN-gamma-independent control of experimental human Cryptosporidium parvum infection.
Robinson P; Okhuysen PC; Chappell CL; Lewis DE; Shahab I; Lahoti S; White AC
Cytokine; 2001 Jul; 15(1):39-46. PubMed ID: 11509007
[TBL] [Abstract][Full Text] [Related]
3. Protection against the early acute phase of Cryptosporidium parvum infection conferred by interleukin-4-induced expression of T helper 1 cytokines.
McDonald SA; O'Grady JE; Bajaj-Elliott M; Notley CA; Alexander J; Brombacher F; McDonald V
J Infect Dis; 2004 Sep; 190(5):1019-25. PubMed ID: 15295711
[TBL] [Abstract][Full Text] [Related]
4. Dynamics of gut mucosal and systemic Th1/Th2 cytokine responses in interferon-gamma and interleukin-12p40 knock out mice during primary and challenge Cryptosporidium parvum infection.
Tessema TS; Schwamb B; Lochner M; Förster I; Jakobi V; Petry F
Immunobiology; 2009; 214(6):454-66. PubMed ID: 19155092
[TBL] [Abstract][Full Text] [Related]
5. Supplementation with Lactobacillus reuteri or L. acidophilus reduced intestinal shedding of cryptosporidium parvum oocysts in immunodeficient C57BL/6 mice.
Alak JI; Wolf BW; Mdurvwa EG; Pimentel-Smith GE; Kolavala S; Abdelrahman H; Suppiramaniam V
Cell Mol Biol (Noisy-le-grand); 1999 Sep; 45(6):855-63. PubMed ID: 10541481
[TBL] [Abstract][Full Text] [Related]
6. Cytokine expression and specific lymphocyte proliferation in two strains of Cryptosporidium parvum-infected gamma-interferon knockout mice.
Smith LM; Bonafonte MT; Mead JR
J Parasitol; 2000 Apr; 86(2):300-7. PubMed ID: 10780549
[TBL] [Abstract][Full Text] [Related]
7. Humoral immune response in IL-12 and IFN-gamma deficient mice after infection with Cryptosporidium parvum.
Jakobi V; Petry F
Parasite Immunol; 2008 Mar; 30(3):151-61. PubMed ID: 18179628
[TBL] [Abstract][Full Text] [Related]
8. Inability of interferon-gamma and aminoguanidine to alter Cryptosporidium parvum infection in mice with severe combined immunodeficiency.
Kuhls TL; Mosier DA; Abrams VL; Crawford DL; Greenfield RA
J Parasitol; 1994 Jun; 80(3):480-5. PubMed ID: 7515109
[TBL] [Abstract][Full Text] [Related]
9. Exogenous interleukin-12 (IL-12) exacerbates Cryptosporidium parvum infection in gamma interferon knockout mice.
Smith LM; Bonafonte MT; Campbell LD; Mead JR
Exp Parasitol; 2001 Jul; 98(3):123-33. PubMed ID: 11527435
[TBL] [Abstract][Full Text] [Related]
10. IL-12 protects immunocompetent and immunodeficient neonatal mice against infection with Cryptosporidium parvum.
Urban JF; Fayer R; Chen SJ; Gause WC; Gately MK; Finkelman FD
J Immunol; 1996 Jan; 156(1):263-8. PubMed ID: 8598471
[TBL] [Abstract][Full Text] [Related]
11. Cryptosporidium parvum infection rapidly induces a protective innate immune response involving type I interferon.
Barakat FM; McDonald V; Foster GR; Tovey MG; Korbel DS
J Infect Dis; 2009 Nov; 200(10):1548-55. PubMed ID: 19821721
[TBL] [Abstract][Full Text] [Related]
12. Substance P expression correlates with severity of diarrhea in cryptosporidiosis.
Robinson P; Okhuysen PC; Chappell CL; Weinstock JV; Lewis DE; Actor JK; White AC
J Infect Dis; 2003 Jul; 188(2):290-6. PubMed ID: 12854086
[TBL] [Abstract][Full Text] [Related]
13. [Highly Active AntiRetroviral Therapy and cryptosporidiosis].
Morales Gomez MA
Parassitologia; 2004 Jun; 46(1-2):95-9. PubMed ID: 15305695
[TBL] [Abstract][Full Text] [Related]
14. Dietary nucleosides and nucleotides reduce Cryptosporidium parvum infection in dexamethasone immunosuppressed adult mice.
Adjei AA; Jones JT; Enriquez FJ; Yamamoto S
Exp Parasitol; 1999 Jul; 92(3):199-208. PubMed ID: 10403761
[TBL] [Abstract][Full Text] [Related]
15. Cytokine profile induced by Cryptosporidium antigen in peripheral blood mononuclear cells from immunocompetent and immunosuppressed persons with cryptosporidiosis.
Gomez Morales MA; La Rosa G; Ludovisi A; Onori AM; Pozio E
J Infect Dis; 1999 Apr; 179(4):967-73. PubMed ID: 10068593
[TBL] [Abstract][Full Text] [Related]
16. Effect of egg yolk antibody on experimental Cryptosporidium parvum infection in scid mice.
Kobayashi C; Yokoyama H; Nguyen SV; Kodama Y; Kimata T; Izeki M
Vaccine; 2004 Nov; 23(2):232-5. PubMed ID: 15531042
[TBL] [Abstract][Full Text] [Related]
17. Cryptosporidium hominis: experimental challenge of healthy adults.
Chappell CL; Okhuysen PC; Langer-Curry R; Widmer G; Akiyoshi DE; Tanriverdi S; Tzipori S
Am J Trop Med Hyg; 2006 Nov; 75(5):851-7. PubMed ID: 17123976
[TBL] [Abstract][Full Text] [Related]
18. Binding and activation of human and mouse complement by Cryptosporidium parvum (Apicomplexa) and susceptibility of C1q- and MBL-deficient mice to infection.
Petry F; Jakobi V; Wagner S; Tessema TS; Thiel S; Loos M
Mol Immunol; 2008 Jul; 45(12):3392-400. PubMed ID: 18501966
[TBL] [Abstract][Full Text] [Related]
19. Dysregulation of interferon-gamma-mediated signalling pathway in intestinal epithelial cells by Cryptosporidium parvum infection.
Choudhry N; Korbel DS; Edwards LA; Bajaj-Elliott M; McDonald V
Cell Microbiol; 2009 Sep; 11(9):1354-64. PubMed ID: 19473199
[TBL] [Abstract][Full Text] [Related]
20. [Human cryptosporidiosis and Cryptosporidium spp. in Haiti].
Raccurt CP; Brasseur P; Verdier RI; Li X; Eyma E; Stockman CP; Agnamey P; Guyot K; Totet A; Liautaud B; Nevez G; Dei-Cas E; Pape JW
Trop Med Int Health; 2006 Jun; 11(6):929-34. PubMed ID: 16772015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
